← Open Payments lookup

PAUL MAYOMBOLA: Open Payments

NPI 1902283534 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$356 in 12 payments from 5 companies in 2025. Trend: 2023 $386 · 2024 $236 · 2025 $356

Food & beverage: $356
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation5$111
ABIOMED3$103
E.R. Squibb & Sons, L.L.C.1$58
Kestra Medical Technology Services, Inc.2$52
Takeda Pharmaceuticals U.S.A., Inc.1$32

Products named: LEQVIO, CAMZYOS, Assure WCD, ENTRESTO, LIVTENCITY.

Industry payments across TX — which companies pay providers there.